Knockdown of the c-Jun N-terminal kinase 2 (JNK2) leads to a diminished breast cancer metastasis to lung and bone as well as to a reduced pro-osteolytic RANKL expression by the breast cancer cells. Here, MAPK9 is linked to breast carcinoma.